Article

FDA Gives Fast Track Designation for Gastric, Gastroesophageal Junction Adenocarcinoma Treatment

Author(s):

The FDA has granted fast track designation to DKN-01 for the treatment of patients with gastric and gastroesophageal junction adenocarcinoma whose tumors have high DKK1 expression.

The FDA has granted a fast track designation to DKN-01 for the treatment of patients with gastric and gastroesophageal junction (GEJ) adenocarcinoma whose tumors have high DKK1 expression, who have progressed on or after a fluoropyrimidine- and platinum-containing chemotherapy, and HER2/neu targeted therapy, if appropriate, according to Leap Therapeutics, Inc.1

“We are pleased with the FDA’s decision to grant fast track designation for the development of DKN-01 to treat patients with gastric and GEJ cancer whose tumor express high levels of DKK1,” Douglas E. Onsi, president and chief executive officer of Leap Therapeutics, Inc, stated in a press release. “The designation highlights the existing unmet medical need for new and effective treatments for this patient population. We believe that DKN-01 shows promise as a novel treatment option for biomarker-selected patients with these cancers, and this designation provides us with earlier and more frequent opportunities to interact with the FDA during the development of DKN-01.”

DKN-01 is a humanized monoclonal antibody that was developed to blind to and block the activity of the DKK1 protein, which serves as a modulator of the Wnt/Beta-catenin signaling pathway that is frequently involved in tumorigenesis and immune system suppression. In the phase 1/2 P102/KEYNOTE-731 trial (NCT02013154) of DKN-01, investigators examined the agent as a monotherapy and in combination regimens in previously treated patients with advanced esophagogastric cancer.2 Participants were given single-agent DKN-01, DKN-01 plus paclitaxel, or DKN-01 plus pembrolizumab (Keytruda).

Click to continue reading on OncLive.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Related Videos
Hematology -- Image credit: DIgilife | stock.adobe.com
Cardiovascular disease doctor or cardiologist holding red heart in clinic or hospital exam room office for csr professional medical service, cardiology health care and world heart health day concept - Image credit: Chinnapong | stock.adobe.com
Image credit: AwieDarwis | stock.adobe.com
Image credit: viperagp | stock.adobe.com
Inflammation concept, inflammated human tissues 3d rendering - Image credit: picture-waterfall | stock.adobe.com